<DOC>
	<DOCNO>NCT01632059</DOCNO>
	<brief_summary>Examination ADMA ( Asymmetric-Dimethylarginine ) -serum level DDAH II ( Dimethylarginine Dimethylaminohydrolase ) - Polymorphism patient severe Sepsis septic shock prognostic value . This study look ADMA good prognostic factor sepsis . Further dependency ADMA level DDAH II polymorphism review study .</brief_summary>
	<brief_title>Examination ADMA Serum Level DDAH II</brief_title>
	<detailed_description>Secondary target mortality ( 28 day ICU ) , length hospitalisation ICU peripheral station , severity illness ( SAPS II score ) , SOFA-score value progress procalcitonin value progress</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>&gt; 18 y/o sepsis septical shock primary cardiogenic shock pregnancy breastfeed non compliance moribund status</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ADMA</keyword>
	<keyword>DDAH II</keyword>
	<keyword>SAPS</keyword>
	<keyword>SOFA</keyword>
	<keyword>Sepsis</keyword>
	<keyword>Procalcitonin</keyword>
	<keyword>ICU</keyword>
	<keyword>mortality</keyword>
	<keyword>length stay</keyword>
</DOC>